Calendar Ascelia Pharma AB

Equities

ACE

SE0010573113

Market Closed - Nasdaq Stockholm 11:29:50 2024-04-26 am EDT 5-day change 1st Jan Change
11.16 SEK +5.28% Intraday chart for Ascelia Pharma AB -15.33% +231.16%

Chart calendar Ascelia Pharma AB

d6518.pC1siWf0fKjJYvRrqsseunpjl7LugZRAW1N9SQa4oG4.xX0q5wqcLPmIKbskm7NT100X-cWg-PMudgpJGkzO6z7eRz7gLcZJzfg1lw~d0f182887af76e96609c2008f7e9f9d0

Upcoming events on Ascelia Pharma AB

2024-05-05 Annual General Meeting
2024-05-15 Q1 2024 Earnings Release
2024-08-14 Q2 2024 Earnings Release
2024-11-06 Q3 2024 Earnings Release
2025-02-06 Q4 2024 Earnings Release
2025-05-06 Q1 2025 Earnings Release (Projected)
2025-08-13 Q2 2025 Earnings Release (Projected)
2025-11-05 Q3 2025 Earnings Release (Projected)
2026-02-05 Q4 2025 Earnings Release (Projected)

Past events on Ascelia Pharma AB

2024-02-09 04:00 am Q4 2023 Earnings Call
2024-02-08 Q4 2023 Earnings Release
2023-11-23 10:10 am Redeye Life Science Day
2023-11-13 10:30 am Extraordinary Shareholders Meeting
2023-11-08 04:00 am Q3 2023 Earnings Call
2023-11-07 Q3 2023 Earnings Release
2023-08-31 12:00 am HC Andersen Capital Life Science Seminar
2023-08-18 04:00 am Q2 2023 Earnings Call
2023-08-18 01:30 am Q2 2023 Earnings Release
2023-08-08 02:00 am SPARKLE Phase 3 Study Results Call
2023-06-23 03:00 am European Association for the Study of the Liver Congress
2023-06-13 03:00 am European Society of Gastrointestinal and Abdominal Radiology Meeting
2023-05-31 08:30 am ABGSC Life Science Summit
2023-05-25 07:00 am Investor Day
2023-05-11 04:00 am Q1 2023 Earnings Call
2023-05-10 Q1 2023 Earnings Release
2023-05-04 08:00 am Annual General Meeting
2023-03-14 09:00 am Investor Meeting
2023-02-10 04:00 am Q4 2022 Earnings Call
2023-02-10 02:00 am Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million SEK
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million SEK
Released
Forecast
Spread
0,00
0,00
-
-93,4
-98,0
4.67%
-138
-134
-3.02%
-147
-129
-14.4%
-111
-116
4.38%

-46,5

EBIT
Million SEK
Released
Forecast
Spread
-37,4
-44,0
15.02%
-93,4
-98,0
4.67%
-138
-134
-2.64%
-147
-129
-14.18%
-111
-116
4.38%

-46,5

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
0,00
0,00
-
-99,7
-96,1
-3.8%
-130
-129
-0.25%
-133
-129
-3.62%
0,00
0,00
-

-37,0

Net income
Million SEK
Released
Forecast
Spread
0,00
0,00
-
-98,7
-96,0
-2.81%
-126
-127
0.47%
-131
-129
-2.12%
0,00
0,00
-

-37,0

EPS
SEK
Released
Forecast
Spread
0,00
0,00
-
-3,76
-3,66
-2.73%
-3,82
-3,85
0.78%
-3,77
-3,73
-1.21%
0,00
0,00
-

-1,29

Announcement Date22/08/1916/02/2110/02/2210/02/2309/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million SEK
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-



0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00

EBITDA
Million SEK
Released
Forecast
Spread












-52,2
-39,0
-33.76%




-33,0





-14,0


-14,0


-14,0


-16,0

EBIT
Million SEK
Released
Forecast
Spread
-39,2
-36,0
-8.78%
-32,6
-37,0
11.97%
-32,7
-37,0
11.75%
-29,6
-36,0
17.73%
-52,2
-39,0
-33.76%



-21,4
-33,0
35.27%




-14,0


-14,0


-14,0


-16,0

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-36,1
-36,0
-0.37%
-30,0
-37,0
18.84%
-23,8
-37,0
35.68%
-26,1
-36,0
27.53%
-53,2
-39,0
-36.51%





















Net income
Million SEK
Released
Forecast
Spread
-35,1
-36,0
2.58%
-29,1
-37,0
21.42%
-22,8
-37,0
38.36%
-26,0
-36,0
27.89%
-53,4
-40,0
-33.46%
-40,3




















EPS
SEK
Released
Forecast
Spread












-1,53
-3,53
56.66%
-1,19


-0,63
-0,90
30%















Announcement Date10/02/2211/05/2218/08/2204/11/2210/02/2318/08/2308/11/2309/02/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ACE Stock
  4. Calendar Ascelia Pharma AB